BackG Medical Innovations Holdings Limited Overview

G Medical Innovations Holdings Limited Long Term Debt

Latest long-term debt for GMVD: $280K.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$283000.00
94.39% YoYΔ $-4.76M vs prior year quarter

Peer trimmed avg / median

Loading

G Medical Innovations Holdings Limited Long Term Debt History

Loading

G Medical Innovations Holdings Limited vs. peers: Long Term Debt Comparison

Loading

G Medical Innovations Holdings Limited Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

G Medical Innovations Holdings Limited (GMVD) FAQ

G Medical Innovations Holdings Limited's long-term debt stands at $280K as of December 2022. That compares with $5M in the prior-year period — down 94.4% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

G Medical Innovations Holdings Limited reported $280K in long-term debt versus $5M a year earlier — a 94.4% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $5M in the prior-year period — down 94.4% year over year. Sustained growth in long-term debt can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how G Medical Innovations Holdings Limited's long-term debt evolved across reporting periods, while the comparison chart places GMVD next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, long-term debt is commonly used to spot outliers. G Medical Innovations Holdings Limited's reading of $280K is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.